Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1Urinary Bladder Neoplasms 1Breast Neoplasms 1

Interventions

Positron Emission Tomography Computed Tomography 2fluciclovine F-18 1abemaciclib 1Valproic Acid 1Tetrahydrouridine 1Sirolimus 1Positron-Emission Tomography 1Oncolytic Virotherapy 1Metformin 1Magnetic Resonance Imaging 1Lapatinib 1Ferrosoferric Oxide 1Fatty Acids, Omega-3 1BCG Vaccine 1Aminophylline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Urinary Bladder Neoplasms × Fatty Acids, Omega-3 × Clear all
NCT03204266 2022-08-24

Oral Supplementation to Enhance Recovery Pilot Study

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
46 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡